查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
输血诊断市场 - 增长、未来展望、竞争分析，2023-2031
市场调查报告书
商品编码
1293826

输血诊断市场 - 增长、未来展望、竞争分析，2023-2031

Blood Transfusion Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格

输血诊断市场是医疗保健行业的重要组成部分，在确保安全高效的输血实践中发挥着关键作用。 预计 2023 年至 2031 年期间，该市场将以 7% 的复合年增长率增长。 该市场的推动因素包括对血液和血液製品的需求不断增长、对输血相关疾病的认识不断提高以及对准确有效的诊断方法的需求。 市场收入稳步增长，预计将继续呈上升趋势。 市场收入受到手术、创伤病例以及慢性病导致的输血数量增加等因素的影响。 此外，血液相关疾病患病率的上升和老年人口的增加也增加了对输血诊断的需求。 技术进步已经开发出创新的诊断方法，可以提供准确、快速的结果，进一步推动市场的增长。 近年来，输血感染的预防和控制越来越受到重视。 这导致了严格的监管指南和质量保证计划的出台，推动了先进输血诊断的采用。 市场正在见证从传统血清学方法向核酸检测 (NAT) 和其他旨在提高灵敏度和特异性的分子技术的转变。

血液和血液製品的需求不断扩大

对血液和血液製品的需求不断增长是输血诊断市场的主要驱动力。 这种需求是由多种因素驱动的，包括手术、创伤和慢性病治疗。 据世界卫生组织 (WHO) 统计，全世界每年估计有 1.125 亿单位的血液捐献。 随着癌症和心血管疾病等在治疗过程中通常需要输血的疾病的患病率不断增加，输血需求预计将进一步增加。

提高对输血感染的认识

人们对输血感染 (TTI) 的认识和关注不断增长，推动了对有效输血诊断的需求。 TTI 是一种传染病，可通过输入受污染的血液或血液製品传播。 医疗当局和血库实施严格的监管指南和质量保证计划，进一步提高了准确可靠诊断的重要性。 例如，美国疾病控制和预防中心 (CDC) 制定了献血者筛查和检测指南，以最大程度地降低 TTI 风险。 这种认识的提高导致了核酸检测（NAT）等先进诊断方法的采用，这些方法能够以更高的灵敏度和特异性检测传染源。

诊断技术的进步

诊断技术的进步对输血诊断市场的增长做出了重大贡献。 创新测试和系统的开发提供了更高的准确性、更快的结果和更高的自动化程度，彻底改变了输血诊断领域。 例如，聚合□炼式反应 (PCR) 和实时 PCR 等 NAT 技术的引入彻底改变了捐献血液中传染性病原体的检测。 这些基于分子的方法具有高灵敏度和特异性，能够及早检测病原体，并降低输血相关感染的风险。 此外，自动化和机器人技术的进步简化了实验室流程，从而提高了输血诊断的通量和效率。 这些技术进步为医疗专业人员提供可靠、高效的工具来确保安全输血，从而继续推动市场向前发展。

监管挑战和严格的合规要求

输血诊断市场的主要限制因素之一是存在监管挑战和严格的合规要求。 输血过程有多项监管标准和指南，旨在确保血液製品的安全和质量。 这些法规的製定是为了最大限度地降低输血相关感染和其他不良事件的风险。 然而，遵守这些法规可能很复杂，并且对医疗机构和血库来说需要资源。 获得监管部门批准、进行验证研究以及遵守质量控制措施的过程可能非常耗时且成本高昂。 此外，监管标准的不断更新和修订也增加了行业参与者面临的挑战。 例如，在美国，血液製品设施受食品药品监督管理局 (FDA) 监管，必须符合 FDA 的现行良好生产规范 (cGMP) 要求。 不遵守规定可能会导致处罚、声誉受损，甚至停业。 此类监管挑战和合规要求限制了市场增长，因为它们增加了开发和商业化的复杂性和成本。

按产品类别划分，设备细分市场占据主导地位

输血诊断市场可按产品细分为试剂和试剂盒、设备和其他。 试剂和试剂盒用于各种检测和化验，如传染病检测、血型测定、相容性试验等，在输血诊断中发挥着重要作用。 这些产品的需求量很大，因为它们是消耗品，需要不断补充。 由于献血活动增加和输血感染流行率上升等因素，预计 2023 年至 2031 年预测期内，试剂和试剂盒细分市场将以最高复合年增长率增长。 仪器，包括自动分析仪和实验室仪器，对于执行诊断测试和获得准确的结果至关重要。 这些仪器提高了效率、准确性和吞吐量，有助于其在输血诊断中的高采用率。 因此，对先进诊断技术的需求和对高效实验室流程的需求将使仪器仪表行业在 2022 年占据收入的很大一部分。 其他部门包括用于输血诊断的辅助产品和配件，例如控製材料、校准器和质量控制解决方案。 儘管该细分市场的市场份额相对较小，但它在支持整个输血诊断过程中发挥着重要作用。

按应用划分的血腥分类细分市场占据主导地位

输血诊断市场按应用分为血型和疾病筛查。 血型鑑定涉及确定个体的血型和 Rh 因子，以确保输血期间供体与受体的相容性。 这是安全、成功输血的重要步骤。 由于血型检测是世界各地血库、医院和实验室的常规检测，因此到2022年，血型检测领域将在市场中占据很大的收入份额。 对血液和血液製品的需求不断增长以及输血程序数量的增加正在推动血型检测领域的增长。 疾病筛查涉及检测和诊断可通过输血传播的各种感染和疾病。 这包括爱滋病毒、肝炎、梅毒和疟疾的疾病筛查。 疾病筛查对于预防传染病传播和保护捐献者和受赠者的健康非常重要。 由于对血液安全的重视以及对传染病检测的严格规定的实施，预计疾病筛查领域在2023-2031年的预测期内将呈现高复合年增长率。

预测期内，北美将引领收入，亚太地区将引领增长

由于其完善的医疗基础设施、高度的血液安全意识和严格的监管标准，北美在 2022 年市场收入中占据很大份额。 该地区还受益于先进的医疗设施和广泛的输血服务。 由于输血程序的增加、血液相关疾病患病率的增加以及先进诊断技术的日益采用，欧洲的市场份额仅次于北美。 由于中国和印度等国家患者数量增加、医疗基础设施改善以及医疗成本上升等因素，预计亚太地区在 2023-2031 年预测期内将呈现最高的复合年增长率。 血液安全意识的提高以及输血程序严格规定的实施也促进了该地区市场的增长。 由于改善医疗设施、提高献血率和加强血液安全措施，拉丁美洲、中东和非洲地区的输血诊断市场呈现稳定增长。

预测期内市场竞争将加剧

输血诊断市场竞争非常激烈，几家主要参与者都在努力增加其在市场上的影响力并获得竞争优势。 市场参与者包括 Bio-Rad Laboratories Inc.、Grifols、Immucor Inc.、Ortho Clinical Diagnostics、Quotient Limited、Beckman Coulter Inc.、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Becton、Dickinson and Company、Siemens Healthineers 等。 这些公司专注于各种战略来维持其市场地位并推动增长。 输血诊断市场公司采取的主要策略之一是产品开发和创新。 市场先驱大力投资于研发活动，以推出技术先进且可靠的诊断解决方案。 目的是提高输血诊断的准确性、速度和效率，提高检测能力，确保血液製品的安全。 合作、伙伴关係和收购是该市场上的公司采取的其他值得注意的策略。 通过战略联盟，公司旨在利用彼此的优势，扩大其地理范围并扩大其产品组合。 与血库、医院和研究机构的合作有助于企业建立强大的客户群并进入更广阔的市场。

内容

第 1 章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法

第 2 章执行摘要

第 3 章输血诊断市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采取的策略
  • 主要产业战略
  • 层级分析：2022 年与 2031 年

第 4 章输血诊断市场：宏观分析和市场动态

  • 简介
  • 2021-2031 年全球输血诊断市场价值
  • 市场动态
    • 市场促进因素
    • 市场抑制因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章输血诊断市场：副产品 2021-2031

  • 市场概况
  • 增长和盈利分析：2022 年与 2031 年
  • 市场细分
    • 试剂和试剂盒
    • 设备
    • 其他

第 6 章输血诊断市场：按应用分类 2021-2031

  • 市场概况
  • 增长和盈利分析：2022 年与 2031 年
  • 市场细分
    • 血型分类
    • 疾病筛查
    • 血清学疾病筛查
    • 分子疾病筛查

第 7 章输血诊断市场：按最终用途 2021-2031

  • 市场概况
  • 增长和盈利分析：2022 年与 2031 年
  • 市场细分
    • 医院
    • 血库
    • 诊断实验室
    • 其他

第 8 章北美输血诊断市场 2021-2031

  • 市场概况
  • 输血诊断市场：2021-2031 年（按产品）
  • 输血诊断市场：按应用分类 2021-2031
  • 输血诊断市场：按最终用途分类 2021-2031 年
  • 输血诊断市场：2021-2031 年地区
    • 北美
      • 美国
      • 加拿大
      • 北美其他地区

第 9 章2021-2031 年英国和欧盟的输血诊断市场

  • 市场概况
  • 输血诊断市场：按产品2021-2031
  • 输血诊断市场：按应用分类 2021-2031
  • 输血诊断市场：按最终用途分类 2021-2031
  • 输血诊断市场：按按产品2021-2031
    • 英国/欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 10 章亚太输血诊断市场 2021-2031

  • 市场概况
  • 输血诊断市场：按产品2021-2031
  • 输血诊断市场：按应用分类 2021-2031
  • 输血诊断市场：按最终用途分类 2021-2031
  • 输血诊断市场：按地区2021-2031
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太地区其他地区

第 11 章拉丁美洲输血诊断市场 2021-2031

  • 市场概况
  • 输血诊断市场：按产品2021-2031
  • 输血诊断市场：按应用分类 2021-2031
  • 输血诊断市场：按最终用途分类 2021-2031
  • 输血诊断市场：按地区2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第 12 章 2021-2031 年中东和非洲输血诊断市场

  • 市场概况
  • 输血诊断市场：按产品2021-2031
  • 输血诊断市场：按应用分类 2021-2031
  • 输血诊断市场：按最终用途分类 2021-2031
  • 输血诊断市场：按地区2021-2031
      • 中东和非洲
        • 海湾合作委员会
        • 非洲
        • 其他中东和非洲地区

    第 13 章公司简介

    • Bio-Rad Laboratories Inc.
    • Grifols
    • Immucor Inc.
    • Ortho Clinical Diagnostics
    • Quotient Limited
    • Beckman Coulter Inc.
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Becton
    • Dickinson and Company
    • Siemens Healthineers
    • 其他特色公司
Product Code: 139607-06-23

The blood transfusion diagnostics market is a critical segment of the healthcare industry that plays a crucial role in ensuring safe and efficient blood transfusion practices. The market is expected to grow at a CAGR of 7% during the forecast period of 2023 to 2031. This market is driven by the increasing demand for blood and blood products, rising awareness about transfusion-transmitted infections, and the need for accurate and efficient diagnostic methods. The market revenue has been steadily growing, and it is expected to continue its upward trajectory in the coming years. The market's revenue is influenced by factors such as the increasing number of blood transfusions due to surgical procedures, trauma cases, and chronic diseases. Additionally, the rising prevalence of blood-related disorders and the growing geriatric population contribute to the demand for blood transfusion diagnostics. The advancements in technology have led to the development of innovative diagnostic methods that provide accurate and rapid results, further fuelling market growth. In recent years, there has been a growing emphasis on the prevention and control of transfusion-transmitted infections. This has led to the introduction of stringent regulatory guidelines and quality assurance programs, which drive the adoption of advanced blood transfusion diagnostics. The market is witnessing a shift from conventional serological methods to nucleic acid testing (NAT) and other molecular techniques for improved sensitivity and specificity.

Growing Demand for Blood and Blood Products

The increasing demand for blood and blood products is a major driver of the blood transfusion diagnostics market. This demand stems from various factors such as surgical procedures, trauma cases, and the treatment of chronic diseases. According to the World Health Organization (WHO), an estimated 112.5 million units of blood donations are collected globally each year. The demand for blood transfusions is expected to rise further due to the growing prevalence of diseases such as cancer and cardiovascular disorders, which often require blood transfusions during treatment.

Rising Awareness about Transfusion-Transmitted Infections

The awareness and concern regarding transfusion-transmitted infections (TTIs) have been on the rise, driving the need for effective blood transfusion diagnostics. TTIs are infections that can be transmitted through the transfusion of contaminated blood or blood products. The implementation of stringent regulatory guidelines and quality assurance programs by healthcare authorities and blood banks has further emphasized the importance of accurate and reliable diagnostics. For example, the Centers for Disease Control and Prevention (CDC) in the United States has established guidelines for the screening and testing of blood donors to minimize the risk of TTIs. This increased awareness has led to the adoption of advanced diagnostic methods, including nucleic acid testing (NAT), to detect infectious agents with higher sensitivity and specificity.

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies have significantly contributed to the growth of the blood transfusion diagnostics market. The development of innovative tests and systems that offer improved accuracy, rapid results, and enhanced automation has transformed the field of blood transfusion diagnostics. For instance, the introduction of NAT techniques, such as polymerase chain reaction (PCR) and real-time PCR, has revolutionized the detection of infectious agents in donated blood. These molecular-based methods offer high sensitivity and specificity, enabling the early detection of pathogens and reducing the risk of transfusion-transmitted infections. Furthermore, advancements in automation and robotics have streamlined laboratory processes, allowing for higher throughput and efficiency in blood transfusion diagnostics. These technological advancements continue to drive the market forward by providing healthcare professionals with reliable and efficient tools for ensuring safe blood transfusions.

Regulatory Challenges and Stringent Compliance Requirements

One of the key restraints in the blood transfusion diagnostics market is the presence of regulatory challenges and stringent compliance requirements. The blood transfusion process involves several regulatory standards and guidelines aimed at ensuring the safety and quality of blood products. These regulations are implemented to minimize the risk of transfusion-transmitted infections and other adverse events. However, compliance with these regulations can be complex and resource-intensive for healthcare facilities and blood banks. The process of obtaining regulatory approvals, conducting validation studies, and adhering to quality control measures can be time-consuming and costly. Additionally, the constant updates and revisions to regulatory standards add to the challenges faced by industry players. For example, in the United States, blood establishments are regulated by the Food and Drug Administration (FDA) and must comply with the FDA's Current Good Manufacturing Practices (cGMP) requirements. Non-compliance can result in penalties, reputational damage, and even the suspension of operations. These regulatory challenges and compliance requirements pose a restraint on market growth, as they increase the complexity and cost of developing and commercializing blood transfusion diagnostics.

Instruments Segment Dominates the Market by Product Categories

The blood transfusion diagnostics market can be segmented based on products into reagents & kits, instruments, and others. Reagents & kits play a crucial role in blood transfusion diagnostics as they are used for various tests and assays to detect infectious agents, blood group typing, and compatibility testing. These products have a high demand due to their consumable nature and the need for continuous replenishment. The reagents & kits segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031, attributed to factors such as increasing blood donation activities and the rising prevalence of transfusion-transmitted infections. Instruments, including automated analyzers and laboratory equipment, are essential for performing diagnostic tests and ensuring accurate results. These instruments offer improved efficiency, precision, and throughput, contributing to their high adoption in blood transfusion diagnostics. The instruments segment, therefore, held a substantial share in terms of revenue in 2022, driven by the demand for advanced diagnostic technologies and the need for efficient laboratory processes. The "others" segment includes ancillary products and accessories used in blood transfusion diagnostics, such as control materials, calibrators, and quality control solutions. Although this segment may have a relatively smaller market share, it plays a vital role in supporting the overall blood transfusion diagnostics process.

Blood Grouping Segment Dominated the Market by Application

The blood transfusion diagnostics market can be categorized based on applications into blood grouping and disease screening. Blood grouping involves determining an individual's blood type and Rh factor to ensure compatibility between the donor and recipient during transfusions. It is an essential step in ensuring safe and successful blood transfusions. The blood grouping segment held a significant revenue share in the market in 2022 as it is a routine procedure performed in blood banks, hospitals, and laboratories worldwide. The increasing demand for blood and blood products, along with the rising number of transfusion procedures, drives the growth of the blood grouping segment. Disease screening involves the detection and diagnosis of various infectious diseases and conditions that can be transmitted through blood transfusions. This includes screening for diseases such as HIV, hepatitis, syphilis, and malaria, among others. Disease screening is critical to prevent the transmission of infections and safeguard the health of both the donor and recipient. The disease screening segment is expected to exhibit a higher CAGR during the forecast period of 2023 to 2031, due to the growing emphasis on blood safety and the implementation of stringent regulations regarding infectious disease testing.

North America to Lead Revenues, While APAC to Lead the Growth During the Forecast Period

North America held a significant share of revenues in the market in 2022 due to well-established healthcare infrastructure, high awareness about blood safety, and stringent regulatory standards. The region also benefits from advanced healthcare facilities and extensive blood transfusion services. Europe follows North America in terms of market share, driven by increasing blood transfusion procedures, rising prevalence of blood-related disorders, and growing adoption of advanced diagnostic technologies. The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period of 2023 to 2031, due to factors such as a large patient population, improving healthcare infrastructure, and increasing healthcare expenditure in countries like China and India. Rising awareness about blood safety and the implementation of strict regulations for blood transfusion procedures also contribute to the market growth in this region. Latin America and the Middle East & Africa regions are witnessing steady growth in the blood transfusion diagnostics market, driven by improving healthcare facilities, increasing blood donation rates, and efforts to enhance blood safety measures.

Market Competition to Intensify During the Forecast Period

The blood transfusion diagnostics market is highly competitive, with several key players striving to enhance their market presence and gain a competitive edge. Prominent companies in the market include Bio-Rad Laboratories Inc., Grifols, Immucor Inc., Ortho Clinical Diagnostics, Quotient Limited, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, and Siemens Healthineers, among others. These players focus on various strategies to maintain their market position and drive growth. One of the key strategies adopted by companies in the blood transfusion diagnostics market is product development and innovation. Market players invest significantly in research and development activities to introduce technologically advanced and reliable diagnostic solutions. They aim to enhance the accuracy, speed, and efficiency of blood transfusion diagnostics, offering improved testing capabilities and ensuring the safety of blood products. Collaborations, partnerships, and acquisitions are other notable strategies employed by companies in this market. Through strategic alliances, companies aim to leverage each other's strengths, expand their geographic reach, and broaden their product portfolios. Collaborations with blood banks, hospitals, and research institutions help companies establish a strong customer base and gain access to a wider market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Blood Transfusion Diagnostics market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Blood Transfusion Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Reagents & Kits
  • Instruments
  • Others

Application

  • Blood Grouping
  • Disease Screening
  • Serological Disease Screening
  • Molecular Disease Screening

End-use

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Blood Transfusion Diagnostics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Blood Transfusion Diagnostics market?
  • Which is the largest regional market for Blood Transfusion Diagnostics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Blood Transfusion Diagnostics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Blood Transfusion Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Blood Transfusion Diagnostics Market
  • 2.2. Global Blood Transfusion Diagnostics Market, By Product, 2022 (US$ Million)
  • 2.3. Global Blood Transfusion Diagnostics Market, By Application, 2022 (US$ Million)
  • 2.4. Global Blood Transfusion Diagnostics Market, By End-use, 2022 (US$ Million)
  • 2.5. Global Blood Transfusion Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Blood Transfusion Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Blood Transfusion Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Blood Transfusion Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Blood Transfusion Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Blood Transfusion Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Reagents & Kits
    • 5.3.2. Instruments
    • 5.3.3. Others

6. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Blood Grouping
    • 6.3.2. Disease Screening
    • 6.3.3. Serological Disease Screening
    • 6.3.4. Molecular Disease Screening

7. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Blood Banks
    • 7.3.3. Diagnostic Laboratories
    • 7.3.4. Others

8. North America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 8.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 8.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 8.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 9.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 9.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 9.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 10.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 10.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 10.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

11. Latin America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 11.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 11.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 11.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 12.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 12.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 12.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Bio-Rad Laboratories Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Grifols
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Immucor Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Ortho Clinical Diagnostics
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Quotient Limited
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Beckman Coulter Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. F. Hoffmann-La Roche Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Abbott Laboratories
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Becton
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Dickinson and Company
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Siemens Healthineers
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Other Notable Players
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 4 North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 7 U.S. Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 10 Canada Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 19 UK Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 22 Germany Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 25 Spain Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 28 Italy Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 France Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 37 Asia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 40 China Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 43 Japan Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 46 India Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 49 Australia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 52 South Korea Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 55 Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 58 Brazil Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 Mexico Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 70 GCC Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 73 Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Blood Transfusion Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Blood Transfusion Diagnostics Market: Quality Assurance
  • FIG. 5 Global Blood Transfusion Diagnostics Market, By Product, 2022
  • FIG. 6 Global Blood Transfusion Diagnostics Market, By Application, 2022
  • FIG. 7 Global Blood Transfusion Diagnostics Market, By End-use, 2022
  • FIG. 8 Global Blood Transfusion Diagnostics Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Blood Transfusion Diagnostics Market, 2022
  • FIG. 10 Market Positioning of Key Blood Transfusion Diagnostics Market Players, 2022
  • FIG. 11 Global Blood Transfusion Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Blood Transfusion Diagnostics Market, By Product, 2022 Vs 2031, %
  • FIG. 13 Global Blood Transfusion Diagnostics Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Blood Transfusion Diagnostics Market, By End-use, 2022 Vs 2031, %
  • FIG. 15 U.S. Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 France Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 China Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 India Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031